Regeneron Pharmaceuticals Inc at Cowen Healthcare Conference (Virtual) Transcript
Good morning, everybody, and thank you once again for joining us for the 31st Annual Cowen Healthcare Conference. I'm Yaron Werber, Biotech Analyst at Cowen, and it's a great pleasure to moderate the fireside chat with Regeneron.
With us today, we have Bob Landry, EVP, Finance and CFO; and Neil Stahl, who is the EVP of R&D. And we have Justin Holko as well if needed.
Gentlemen, thanks so much for joining us. We appreciate it.
So we have a lot to cover. Absolutely, a lot going on in Regeneron. So Bob, maybe do you want to kick it off with forward-looking statements and give us your kind of opening remarks?
Sure. Thanks. And again, thank you for inviting Regeneron to the conference. Always really good to be here.
So before we begin, let me remind you, remarks made in the webcast include forward-looking statements about Regeneron.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
